International Patent: ANTIBODY WHICH BINDS TO HUMAN SRRM2 PRESENT ON THE CELL SURFACE OF A TARGET CELL FOR USE IN THE TREATMENT OF A SOLID TUMOR

GENEVA, Aug. 14 -- ZENO THERAPEUTICS PTE. LTD. filed a patent application (CN2025/075803) for “ANTIBODY WHICH BINDS TO HUMAN SRRM2 PRESENT ON THE CELL SURFACE OF A TARGET CELL FOR USE IN THE TREATMENT OF A SOLID TUMOR”. With publication no. WO/2026/165708, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/18

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....